Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 700

1.

RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.

Walsh PC.

J Natl Cancer Inst. 2018 Oct 30. doi: 10.1093/jnci/djy186. [Epub ahead of print] No abstract available.

PMID:
30380081
2.

Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.

Moyer CL, Phillips R, Deek MP, Radwan N, Ross AE, Antonarakis ES, Reyes D, Wright J, Terezakis SA, Song DY, DeVille C, Walsh PC, DeWeese TL, Carducci M, Schaeffer EM, Pienta KJ, Eisenberger M, Tran PT.

World J Urol. 2018 Sep 6. doi: 10.1007/s00345-018-2477-2. [Epub ahead of print]

PMID:
30191396
3.

Germline mutations in PPFIBP2 are associated with lethal prostate cancer.

Wu Y, Yu H, Zheng SL, Feng B, Kapron AL, Na R, Boyle JL, Shah S, Shi Z, Ewing CM, Wiley KE, Luo J, Walsh PC, Carter HB, Helfand BT, Cooney KA, Xu J, Isaacs WB.

Prostate. 2018 Dec;78(16):1222-1228. doi: 10.1002/pros.23697. Epub 2018 Jul 24.

PMID:
30043417
4.

Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.

Helfand BT, Chen H, Fantus RJ, Conran CA, Brendler CB, Zheng SL, Walsh PC, Isaacs WB, Xu J.

Prostate. 2018 Jun 19. doi: 10.1002/pros.23664. [Epub ahead of print]

PMID:
29923209
5.

Magnetic Resonance Imaging Prior to First Prostate Biopsy-Are we there yet?

Gorin MA, Walsh PC.

Eur Urol. 2018 Oct;74(4):409-410. doi: 10.1016/j.eururo.2018.05.018. Epub 2018 Jun 14. No abstract available.

PMID:
29866464
6.

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.

J Clin Oncol. 2018 Feb 1;36(4):414-424. doi: 10.1200/JCO.2017.74.1173. Epub 2017 Dec 13.

7.

Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?

Ludwig WW, Feng Z, Trock BJ, Humphreys E, Walsh PC.

J Urol. 2018 Jan;199(1):114-119. doi: 10.1016/j.juro.2017.08.041. Epub 2017 Aug 14.

PMID:
28818527
8.

A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

Na R, Helfand BT, Chen H, Conran CA, Crawford SE, Hayward SW, Tammela TLJ, Hoffman-Bolton J, Zheng SL, Walsh PC, Schleutker J, Platz EA, Isaacs WB, Xu J.

Prostate. 2017 Aug;77(11):1213-1220. doi: 10.1002/pros.23380. Epub 2017 Jun 28.

9.

Prostate Cancer Screening.

Walsh PC.

N Engl J Med. 2017 Jun 15;376(24):2401-2. doi: 10.1056/NEJMc1705480. No abstract available.

PMID:
28614679
10.

If You Want to Make an Important Discovery, Listen to Your Patients.

Walsh PC.

Eur Urol. 2017 Oct;72(4):482. doi: 10.1016/j.eururo.2017.04.001. Epub 2017 Apr 22.

PMID:
28442164
11.

The Search for the Missing Heritability of Prostate Cancer.

Walsh PC.

Eur Urol. 2017 Nov;72(5):657-659. doi: 10.1016/j.eururo.2017.04.003. Epub 2017 Apr 22.

PMID:
28442163
12.

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease.

Tosoian JJ, Alam R, Gergis C, Narang A, Radwan N, Robertson S, McNutt T, Ross AE, Song DY, DeWeese TL, Tran PT, Walsh PC.

Prostate Cancer Prostatic Dis. 2017 Jun;20(2):193-196. doi: 10.1038/pcan.2016.64. Epub 2017 Jan 3.

13.

Impotence Following Radical Prostatectomy: Insight into Etiology and Prevention.

Walsh PC, Donker PJ.

J Urol. 2017 Feb;197(2S):S165-S170. doi: 10.1016/j.juro.2016.10.105. Epub 2016 Dec 21.

PMID:
28012765
14.

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

Na R, Zheng SL, Han M, Yu H, Jiang D, Shah S, Ewing CM, Zhang L, Novakovic K, Petkewicz J, Gulukota K, Helseth DL Jr, Quinn M, Humphries E, Wiley KE, Isaacs SD, Wu Y, Liu X, Zhang N, Wang CH, Khandekar J, Hulick PJ, Shevrin DH, Cooney KA, Shen Z, Partin AW, Carter HB, Carducci MA, Eisenberger MA, Denmeade SR, McGuire M, Walsh PC, Helfand BT, Brendler CB, Ding Q, Xu J, Isaacs WB.

Eur Urol. 2017 May;71(5):740-747. doi: 10.1016/j.eururo.2016.11.033. Epub 2016 Dec 15.

15.

Technique and outcomes of bladder neck intussusception during robot-assisted laparoscopic prostatectomy: A parallel comparative trial.

Tan HJ, Xiong S, Laviana AA, Chuang RJ, Treat E, Walsh PC, Hu JC.

Urol Oncol. 2016 Dec;34(12):529.e1-529.e7. doi: 10.1016/j.urolonc.2015.01.012. Epub 2016 Oct 12.

PMID:
27743849
16.

Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series.

Ball MW, Harris KT, Schwen ZR, Mullins JK, Han M, Walsh PC, Partin AW, Epstein JI.

BJU Int. 2017 Mar;119(3):444-448. doi: 10.1111/bju.13654. Epub 2016 Sep 30.

17.

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.

Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Giles GG, Southey MC, Fitzgerald LM, Rinckleb A, Luedeke M, Maier C, Stanford JL, Ostrander EA, Kaikkonen EM, Sipeky C, Tammela T, Schleutker J, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cancel-Tassin G, Cussenot O, Mandal D, Laurie C, Laurie C; PRACTICAL consortium; International Consortium for Prostate Cancer Genetics, Thibodeau SN, Eeles RA, Kote-Jarai Z, Cannon-Albright L.

Hum Genet. 2016 Aug;135(8):923-38. doi: 10.1007/s00439-016-1690-6. Epub 2016 Jun 4.

19.

Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection.

Sutcliffe S, Nevin RL, Pakpahan R, Elliott DJ, Langston ME, De Marzo AM, Gaydos CA, Isaacs WB, Nelson WG, Sokoll LJ, Walsh PC, Zenilman JM, Cersovsky SB, Platz EA.

Int J Cancer. 2016 May 1;138(9):2221-30. doi: 10.1002/ijc.29966. Epub 2016 Jan 21.

20.

Immediate Adjuvant Radiation Therapy Following Radical Prostatectomy Should Not Be Advised for Men with Extraprostatic Extension Who Have Negative Surgical Margins.

Walsh PC, Lawrentschuk N.

Eur Urol. 2016 Feb;69(2):191-2. doi: 10.1016/j.eururo.2015.09.045. Epub 2015 Oct 23.

PMID:
26470628

Supplemental Content

Loading ...
Support Center